Tech Company Financing Transactions
Bactolife Funding Round
On 8/8/2023, Bactolife raised $33.1 million in Series A funding from Athos, Bill & Melinda Gates Foundation and Novo Holdings.
Transaction Overview
Company Name
Announced On
8/8/2023
Transaction Type
Venture Equity
Amount
$33,080,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its most mature projects towards commercial launch and strengthen the technology platform and upscaling capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Rønnegade 8
Copenhagen, 2100
Denmark
Copenhagen, 2100
Denmark
Phone
Undisclosed
Website
Email Address
Overview
We strive to empower worldwide health through a fortified gut microbiome. We take a unique approach to worldwide health for the greater good of humans and animals by making breakthrough Binding Proteins accessible to all.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mads Laustsen
Chief Financial Officer
Sebastian Søderberg
Chief Operating Officer
Anders Gram
Chief Scientific Officer
Sandra Thrane
Chief Technical Officer
Andreas Laustsen-Kiel
VP - Regulatory Affairs
Christel Jørgensen
Browse more venture capital transactions:
Prev: 8/8/2023: Daybreak Health venture capital transaction
Next: 8/8/2023: VIP3.io venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs